Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Franco

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Pathogens (Basel, Switzerland)|April 3, 2021
One Health Approach to Zoonotic Parasites: Molecular Detection of Intestinal Protozoans in an Urban Population of Norway Rats, <i>Rattus norvegicus</i>, in Barcelona, SpainMaría Teresa Galán-Puchades, María Trelis, Sandra Sáez-Durán, et al.
AIDS (London, England)|September 5, 2021
Single nucleotide polymorphisms in PNPLA3, ADAR-1 and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1//hepatitis C virusSandra Franco, Judith Horneros, Laura Soldevila, et al.
European Journal of Medicinal Chemistry|April 8, 2016
Design, synthesis and biological evaluation of pyrido[2,3-d]pyrimidin-7-(8H)-ones as HCV inhibitorsMarta Camarasa, Raimon Puig de la Bellacasa, Àlex L González, et al.
Emerging Infectious Diseases|May 21, 2019
Leishmaniasis in Norway Rats in Sewers, Barcelona, SpainMaria Teresa Galán-Puchades, Mercedes Gómez-Samblás, Jose M Suárez-Morán, et al.
Clinical Drug Investigation|September 11, 2023
Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed AppropriateLuis Fein, Nicolas Lazaretti, Yamil López Chuken, et al.
Clinical Drug Investigation|August 18, 2023
Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed AppropriateLuis Fein, Nicolas Lazaretti, Yamil López Chuken, et al.
Antiviral Research|June 16, 2018
ADAR1 affects HCV infection by modulating innate immune responseMaria Pujantell, Sandra Franco, Iván Galván-Femenía, et al.
Journal of Surgical Oncology|June 27, 2024
Selecting postoperative adjuvant systemic therapy for early-stage breast cancer: An updated assessment and systematic review of leading commercially available gene expression assaysDavid M Hyams, Avital Bareket-Samish, Juan Enrique Bargallo Rocha, et al.
JMIR Formative Research|March 13, 2025
Teen Perspectives on Integrating Digital Mental Health Programs for Teens Into Public Libraries ("I Was Always at the Library"): Qualitative Interview StudyAshley A Knapp, Katherine Cohen, Kaylee P Kruzan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2016
Human DDX3 protein is a valuable target to develop broad spectrum antiviral agentsAnnalaura Brai, Roberta Fazi, Cristina Tintori, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Pathogens (Basel, Switzerland)|April 3, 2021
One Health Approach to Zoonotic Parasites: Molecular Detection of Intestinal Protozoans in an Urban Population of Norway Rats, <i>Rattus norvegicus</i>, in Barcelona, SpainMaría Teresa Galán-Puchades, María Trelis, Sandra Sáez-Durán, et al.
AIDS (London, England)|September 5, 2021
Single nucleotide polymorphisms in PNPLA3, ADAR-1 and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1//hepatitis C virusSandra Franco, Judith Horneros, Laura Soldevila, et al.
European Journal of Medicinal Chemistry|April 8, 2016
Design, synthesis and biological evaluation of pyrido[2,3-d]pyrimidin-7-(8H)-ones as HCV inhibitorsMarta Camarasa, Raimon Puig de la Bellacasa, Àlex L González, et al.
Emerging Infectious Diseases|May 21, 2019
Leishmaniasis in Norway Rats in Sewers, Barcelona, SpainMaria Teresa Galán-Puchades, Mercedes Gómez-Samblás, Jose M Suárez-Morán, et al.
Clinical Drug Investigation|September 11, 2023
Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed AppropriateLuis Fein, Nicolas Lazaretti, Yamil López Chuken, et al.
Clinical Drug Investigation|August 18, 2023
Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed AppropriateLuis Fein, Nicolas Lazaretti, Yamil López Chuken, et al.
Antiviral Research|June 16, 2018
ADAR1 affects HCV infection by modulating innate immune responseMaria Pujantell, Sandra Franco, Iván Galván-Femenía, et al.
Journal of Surgical Oncology|June 27, 2024
Selecting postoperative adjuvant systemic therapy for early-stage breast cancer: An updated assessment and systematic review of leading commercially available gene expression assaysDavid M Hyams, Avital Bareket-Samish, Juan Enrique Bargallo Rocha, et al.
JMIR Formative Research|March 13, 2025
Teen Perspectives on Integrating Digital Mental Health Programs for Teens Into Public Libraries ("I Was Always at the Library"): Qualitative Interview StudyAshley A Knapp, Katherine Cohen, Kaylee P Kruzan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2016
Human DDX3 protein is a valuable target to develop broad spectrum antiviral agentsAnnalaura Brai, Roberta Fazi, Cristina Tintori, et al.
Pageof 10